Project Grant S10OD038149

Award Date 5/15/25
Completion Date 5/14/26
Dollars Obligated $1.6M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
The National Institutes of Health (NIH) awarded a $1,089,778 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to The Regents of the University of Colorado (CU), Boulder. The grant will fund the acquisition of a high-resolution liquid chromatography-mass spectrometry system to support small molecule and biomolecule analysis at CU-Boulder's Central Analytical Laboratory. The new instrument, consisting of a Waters SELECT SERIES CYCLIC IMS QTOF mass spectrometer, ACQUITY...
This Project Grant award, totaling $1,759,412.00, was provided by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351). The funding will support the acquisition of a Bruker 'timsTOF Flex MALDI-2' mass spectrometry system, including an HTX M3+ sprayer, at the Buck Institute for Research on Aging in Novato, California. This advanced instrumentation will enable spatially resolved molecular imaging of human and animal tissues and organoids, facilitating...
This $949,116 federal Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system at the University of South Florida (USF). This state-of-the-art instrumentation will establish a unique omics research capability for detailed, high-resolution structural analysis of low-level small molecules in complex...
This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $287,665 to the University of Wisconsin-Madison to acquire a Waters ACQUITY UPLC with a photodiode array and single-quadrupole mass spectrometer. The instrument will be used to characterize novel molecules synthesized by several research groups at the university, supporting projects focused on developing new therapies and drugs to improve human health....
The National Science Foundation (NSF) awarded a $636,312 Project Grant through its Integrative Activities program (CFDA 47.083) to the University of Southern Mississippi to acquire a state-of-the-art high-resolution liquid chromatography-mass spectrometer (LC-MS) system. This equipment will enhance the university's research, education, and outreach capabilities. The LC-MS instrument will allow graduate and undergraduate students to gain valuable skills in high-resolution mass spectrometry and...
This Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $1,481,998.00 to the University of Illinois Chicago (UIC) to acquire a dual-source ion mobility mass spectrometry system. This state-of-the-art instrumentation will enable advanced biomedical research capabilities at UIC and support collaborations with researchers across the Midwest, nationally, and internationally. The...
This Project Grant award from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) provides $940,303 to the University of California, Merced (UC Merced) to acquire a state-of-the-art TimsTOF Pro 2 mass spectrometer coupled to a liquid chromatography system. This instrumentation will enhance UC Merced's capacity to conduct advanced biomolecular research into host-microbe interactions, enabling the separation, detection, and identification of proteins and...
This National Science Foundation (NSF) Integrative Activities (CFDA 47.083) Project Grant award of $401,144 to the University of the Pacific (Stockton, CA) will fund the acquisition of a Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometer (MALDI-TOF-MS). This high-resolution mass spectrometry instrument will support collaborative research and educational programs across multiple departments at the university. The grant will enable advanced structural analyses of...
The National Institutes of Health Office of the Director awarded Stanford University $3.8 million under the Research Infrastructure Programs grant program (CFDA 93.351) to acquire a new Orbitrap Tribrid mass spectrometry platform. For over 20 years, Stanford University Mass Spectrometry has served as the campus-wide shared proteomics resource, housing and maintaining mass spectrometry instruments to support numerous NIH-funded biomedical research projects spanning human development, degenerative...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,469,739 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the Research Foundation of the City University of New York (RFCUNY) - Advanced Science Research Center (ASRC). The award, which runs from August 15, 2024 to August 14, 2025, will fund the acquisition of a TIMSTOF-FLEX MALDI-2 high-resolution mass spectrometer with trapped-ion mobility and dual ion-source capabilities. This...

This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $1,574,994 to the University of California, Los Angeles (UCLA) to acquire a state-of-the-art high-resolution tandem mass spectrometer. This specialized instrument will support structural characterization of a broad range of large biological and synthetic molecules across over 11 NIH-funded research projects at the university. The mass spectrometer's capabilities for high-accuracy mass measurements, multistage MS-n experiments, and diverse fragmentation methods will enable advanced top-down analysis to elucidate the sequence, structure, and post-translational modifications of large biomolecules. This equipment will be a vital component for research addressing human health issues including neurodegenerative diseases, infectious diseases, cancer, and viral infections. The award has a performance period from May 15, 2025 to May 14, 2026.

Generated 6/17/25, 5:34 AM